Literature DB >> 16520952

Clinical course of 110 children and adolescents with primary focal segmental glomerulosclerosis.

Marcelo M Abrantes1, Luis Sergio B Cardoso, Eleonora M Lima, Jose Maria P Silva, Jose S Diniz, Eduardo A Bambirra, Eduardo A Oliveira.   

Abstract

The purpose of this retrospective cohort study was to report the clinical course of children and adolescents with primary focal segmental glomerulosclerosis (FSGS). The records of 110 patients with biopsy-proven FSGS admitted between 1972 and 2004 were retrospectively reviewed. Demographic, clinical and laboratory data were recorded and histopathological data were reanalyzed by one pathologist who had no information about the outcome of the patients. Renal survival analysis was performed using the Kaplan-Meier method. Differences between subgroups (response to corticosteroids) were assessed by the two-sided log rank test. The median age at admission was 5 years (range: 1-15 years). Forty-two patients (38.2%) presented with hematuria at admission, and 55 (50%) presented blood pressure levels above the 95th percentile. Mean follow-up time was 10 years (SD 5.5). Twenty-four patients (21.8%) presented chronic kidney disease (CKD). It was estimated that the probability of CKD was 8% at 5 years, 17% at 10 years, and 32% at 15 years after diagnosis of nephrotic syndrome. In conclusion, on the basis of the clinical and histological characteristics observed, apparently our cohort of idiopathic FSGS is comparable with other published series. However, the long-term overall renal survival seems to be better in our cohort.

Entities:  

Mesh:

Year:  2006        PMID: 16520952     DOI: 10.1007/s00467-006-0019-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  39 in total

Review 1.  The many masks of focal segmental glomerulosclerosis.

Authors:  V D'Agati
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612

2.  Changing patterns in the histopathology of idiopathic nephrotic syndrome in children.

Authors:  M Bonilla-Felix; C Parra; T Dajani; M Ferris; R D Swinford; R J Portman; R Verani
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

3.  Primary focal segmental glomerulosclerosis in children: prognostic factors.

Authors:  R Martinelli; A S Okumura; L J Pereira; H Rocha
Journal:  Pediatr Nephrol       Date:  2001-08       Impact factor: 3.714

4.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

5.  Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

Authors:  Rainer G Ruf; Anne Lichtenberger; Stephanie M Karle; Johannes P Haas; Franzisco E Anacleto; Michael Schultheiss; Isabella Zalewski; Anita Imm; Eva-Maria Ruf; Bettina Mucha; Arvind Bagga; Thomas Neuhaus; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

6.  The long-term prognosis of patients with focal segmental glomerulosclerosis.

Authors:  J S Cameron; D R Turner; C S Ogg; C Chantler; D G Williams
Journal:  Clin Nephrol       Date:  1978-12       Impact factor: 0.975

7.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

8.  Focal segmental glomerulosclerosis with and without nephrotic syndrome in children.

Authors:  N Yoshikawa; H Ito; R Akamatsu; S Matsuyama; O Hasegawa; C Nakahara; T Matsuo
Journal:  J Pediatr       Date:  1986-07       Impact factor: 4.406

9.  Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study.

Authors:  M Haas; B H Spargo; S Coventry
Journal:  Am J Kidney Dis       Date:  1995-11       Impact factor: 8.860

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  10 in total

1.  Glomerular nestin expression: possible predictor of outcome of focal segmental glomerulosclerosis in children.

Authors:  Maja Životić; Radovan Bogdanović; Amira Peco-Antić; Dušan Paripović; Nataša Stajić; Jelena Vještica; Sanja Ćirović; Goran Trajković; Jasmina Marković-Lipkovski
Journal:  Pediatr Nephrol       Date:  2014-08-18       Impact factor: 3.714

2.  Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis.

Authors:  Marcelo M Abrantes; Luis Sergio B Cardoso; Eleonora M Lima; José M Penido Silva; José S Diniz; Eduardo A Bambirra; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

3.  Primary focal segmental glomerular sclerosis in children: clinical course and prognosis.

Authors:  Kyung Hoon Paik; Bum Hee Lee; Hee Yeon Cho; Hee Gyung Kang; Il Soo Ha; Hae Il Cheong; Dong-Kyu Jin; Kyung Chul Moon; Yong Choi
Journal:  Pediatr Nephrol       Date:  2006-10-21       Impact factor: 3.714

4.  Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.

Authors:  Alanoud Alshami; Abishek Roshan; Marisa Catapang; Jasper J Jöbsis; Trevor Kwok; Nonnie Polderman; Jennifer Sibley; Matt Sibley; Cherry Mammen; Douglas G Matsell
Journal:  Pediatr Nephrol       Date:  2017-05-24       Impact factor: 3.714

5.  Primary focal segmental glomerulosclerosis in Egyptian children: a 10-year single-centre experience.

Authors:  Ahmed M El-Refaey; Ashraf Bakr; Ayman Hammad; Atef Elmougy; Fatma El-Houseeny; Ashraf Abdelrahman; Amr Sarhan
Journal:  Pediatr Nephrol       Date:  2010-03-02       Impact factor: 3.714

6.  Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group.

Authors:  Alexandra Peyser; Nathaniel Machardy; Freya Tarapore; Jacqueline Machardy; Leslie Powell; Debbie S Gipson; Virginia Savin; Cynthia Pan; Theresa Kump; Suzanne Vento; Howard Trachtman
Journal:  BMC Nephrol       Date:  2010-01-29       Impact factor: 2.388

7.  Therapies for steroid-resistant nephrotic syndrome.

Authors:  Elisabeth M Hodson; Jonathan C Craig
Journal:  Pediatr Nephrol       Date:  2008-03-27       Impact factor: 3.714

8.  Frequency and clinicopathological correlations of histopathological variants of pediatric idiopathic focal segmental glomerulosclerosis.

Authors:  S Shakeel; M Mubarak; J I Kazi
Journal:  Indian J Nephrol       Date:  2014-05

9.  Serological markers of viral, syphilitic and toxoplasmic infection in children and teenagers with nephrotic syndrome: case series from Mato Grosso State, Brazil.

Authors:  Silvania França da Silva Soares; Teresinha Lermen Donatti; Francisco José Dutra Souto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Nov-Dec       Impact factor: 1.846

10.  Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis.

Authors:  Dawn J Caster; Barbara Magalhaes; Natali Pennese; Andrea Zaffalon; Marina Faiella; Kirk N Campbell; Jai Radhakrishnan; Vladmir Tesar; Howard Trachtman
Journal:  Kidney Med       Date:  2022-06-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.